Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Matrix-assisted laser desorption ionization-time of flight and comparative genomic analysis of M-18 group a Streptococcus strains associated with an acute rheumatic fever outbreak in northeast Italy in 2012 and 2013.
Gaibani P, Scaltriti E, Foschi C, Baggio E, Tamburini MV, Creti R, Pascucci MG, Fagioni M, Ambretti S, Comandatore F, Pongolini S, Landini MP. Gaibani P, et al. J Clin Microbiol. 2015 May;53(5):1562-72. doi: 10.1128/JCM.03465-14. Epub 2015 Mar 4. J Clin Microbiol. 2015. PMID: 25740772 Free PMC article.
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF).
Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Tonetti T, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. J Crit Care. 2023 Aug;76:154301. doi: 10.1016/j.jcrc.2023.154301. Epub 2023 Apr 12. J Crit Care. 2023. PMID: 37059003 Free article.
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF).
Gatti M, Rinaldi M, Tonetti T, Gaibani P, Siniscalchi A, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. Int J Antimicrob Agents. 2023 Aug;62(2):106852. doi: 10.1016/j.ijantimicag.2023.106852. Epub 2023 May 14. Int J Antimicrob Agents. 2023. PMID: 37192727
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia.
Gatti M, Giannella M, Rinaldi M, Gaibani P, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. Antibiotics (Basel). 2022 Dec 2;11(12):1739. doi: 10.3390/antibiotics11121739. Antibiotics (Basel). 2022. PMID: 36551398 Free PMC article.
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection due to OXA-181-producing Klebsiella pneumoniae.
Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. J Glob Antimicrob Resist. 2023 Sep;34:268-270. doi: 10.1016/j.jgar.2023.05.007. Epub 2023 Jun 1. J Glob Antimicrob Resist. 2023. PMID: 37269975 Free article. No abstract available.
Blood culture systems: rapid detection--how and why?
Gaibani P, Rossini G, Ambretti S, Gelsomino F, Pierro AM, Varani S, Paolucci M, Landini MP, Sambri V. Gaibani P, et al. Int J Antimicrob Agents. 2009;34 Suppl 4:S13-5. doi: 10.1016/S0924-8579(09)70559-X. Int J Antimicrob Agents. 2009. PMID: 19931809
Chikungunya: an emerging and spreading arthropod-borne viral disease.
Cavrini F, Gaibani P, Pierro AM, Rossini G, Landini MP, Sambri V. Cavrini F, et al. Among authors: gaibani p. J Infect Dev Ctries. 2009 Dec 15;3(10):744-52. doi: 10.3855/jidc.169. J Infect Dev Ctries. 2009. PMID: 20009275 Free article. Review.
133 results